PRODUCT CENTER
Innovative Pharmaceuticals
Pharmaceutical Intermediates
Manareco focuses on small-molecule chemical drugs and medium-molecule biologics in the pharmaceutical intermediate segment, providing CMO/CDMO one-stop services for globally renowned pharmaceutical enterprises. The company has over 350 innovative drug pipelines, covering anti-tumor, psychiatric, immunology, cardiovascular, anti-infective and other therapeutic areas, with services covering the whole drug lifecycle from preclinical research to commercial production. Core pipelines have reached in-depth strategic cooperation with multiple international top-tier pharmaceutical enterprises, forming a stable and sustainable commercial cooperation system.
In the peptide field, the company focuses on high-barrier unnatural amino acids and short peptides, relying on core technologies such as asymmetric synthesis, continuous flow chemistry and enzyme catalysis to greatly improve process efficiency and reduce production costs, providing key support for innovative drug R&D and industrialization.
Manareco has formed a complete business pattern of “intermediates as the core, APIs as the lead, and CDMO as the support” in the innovative pharmaceutical field. With core technologies such as fine organic synthesis, impurity research and trace analysis, as well as R&D-production synergy advantages, the company has prominent competitive strength in the domestic innovative pharmaceutical intermediate and CDMO field, with obvious differentiated advantages in segmented tracks.
Active Pharmaceutical Ingredients (APIs)
The company has completed Phase I construction of Manareco Pharmaceutical, the API production base, in accordance with US cGMP and China GMP standards. Phase I has built 5 production lines, meeting the needs of pilot scale-up and commercial production of APIs from gram level to 100kg level, with OEB3~OEB5 grades. Since the completion of Phase I, the company has successively obtained the Drug Manufacturing Licenseissued by China’s drug regulatory authority, GMP compliance inspection notice, Foreign Manufacturer Accreditation Certificate for Pharmaceuticalsissued by Japan’s Ministry of Health, Labour and Welfare, CEP certificates issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), Written Confirmation (WC) for API export to the EU, and the national High-Tech Enterprise Certificate. So far, the company has realized the industrial chain extension from pharmaceutical intermediates to APIs, and achieved the phased strategic goal of “intermediate + API” integrated CMO/CDMO.
By the end of 2025, Manareco Pharmaceutical has passed multiple domestic and overseas customer audits, drug registration inspections and GMP inspections, and successfully completed R&D and marketing applications for more than 10 APIs and pharmaceutical excipients in China, the United States, the European Union and Japan. Some APIs such as Posaconazole and Gadobutrol have been approved for marketing and generated revenue. With the commercial production of various varieties, the company’s “intermediate + API” integration and industrial chain advantages will become increasingly prominent.
keyword：
chemical,pharmaceutical
category：
Product
ONLINE MESSAGE
Note: Please ensure that the information you provide is accurate and keep the communication channels open. We will contact you as soon as possible.
OLED materials are the core functional components of organic light-emitting diodes, mainly categorized into emission layer materials (red/green/blue hosts and dopants), hole/electron transport layers, injection layers, encapsulation adhesives, etc.
Manareco focuses on small-molecule chemical drugs and medium-molecule biologics in the pharmaceutical intermediate segment, providing CMO/CDMO one-stop services for globally renowned pharmaceutical enterprises.
Based on the long-term cooperative relationships with globally renowned enterprises, the company has accumulated expertise in synthetic purification, metal ion analysis and removal capabilities, pilot-scale production advantages, and enjoys a strong reputation in the Japanese market.